Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 07782B104 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Yu-Hsin Lin 13G/A Amendment 1 | 3.1% |
5/14/2026
Event 3/31/2026
|
|
|
Darwin Global Management, Ltd.
13G/A
Amendment 1
|
8.1% |
2/17/2026
Event 12/31/2025
|
|
| Darwin Global Management, Ltd. | 8.1% | ||
| Trehan Abhishek | 8.1% | ||
| Darwin Global Master Fund, Ltd. | 7.8% | ||
|
Darwin Global Management, Ltd.
13G
|
7.0% |
12/10/2025
Event 12/3/2025
|
|
| Darwin Global Management, Ltd. | 7.0% | ||
| Dr. Abhishek Trehan | 7.0% | ||
| Darwin Global Master Fund, Ltd. | 6.7% | ||
| Yu-Hsin Lin 13G | 7.1% |
1/21/2025
Event 12/31/2024
|
|
| Lin Bioscience International Ltd. 13G | 53.7% |
1/21/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 1.83 k | $311 k |
| 2026 Q2 | 80 | 9.47 M | $1.44 B |
| 2026 Q1 | 75 | 9.12 M | $1.42 B |
| 2025 Q4 | 70 | 7.19 M | $1.15 B |
| 2025 Q3 | 35 | 2.30 M | $170 M |
| 2025 Q2 | 19 | 78.1 k | $4.51 M |
| 2025 Q1 | 19 | 150 k | $9.91 M |
| 2024 Q4 | 23 | 282 k | $17.8 M |
| 2024 Q3 | 17 | 85.1 k | $3.99 M |
| 2024 Q2 | 14 | 188 k | $8.57 M |
| 2024 Q1 | 15 | 71.0 k | $2.72 M |
| 2023 Q4 | 20 | 192 k | $8.77 M |
| 2023 Q3 | 8 | 99.6 k | $3.17 M |
| 2023 Q2 | 7 | 1.04 M | $14.9 M |
| 2023 Q1 | 9 | 850 k | $25.4 M |
| 2022 Q4 | 9 | 869 k | $26.2 M |
| 2022 Q3 | 9 | 115 k | $3.87 M |
| 2022 Q2 | 7 | 68.9 k | $2.15 M |